Healthcare Costs and Policy Issues

This living topic examines the complexities and challenges surrounding healthcare costs and policies in the United States. Key issues include the dramatic price hikes in essential medications like the EpiPen, the high costs of prescription drugs and healthcare services, and the inefficiencies in the U.S. healthcare system despite substantial spending. Articles explore the impact of these costs on consumers, the roles of monopolies and patents in driving prices up, and the legislative and policy responses to these challenges. The topic also delves into specific concerns like medication errors, employer-sponsored health insurance costs, and the public health crisis of gun violence, highlighting the need for systemic reforms and more effective regulatory measures.

Latest

Court orders Trump admin to stop cutting medical research funding after 22 states sue

Trump admin said the cuts will save money going to "administrative overhead"

Featured Health News photo

A district court in Massachussetts issued a temporary restraining order on Monday barring an effort by the Trump administration to cut billions of dollars in funding for medical research that was already approved.

The order follows a lawsuit from the attorneys general of 22 states against the Trump administration the same day, which argued the cuts will harm medical research and the health of Americans.

The lawsuit, filed by states including California, Michigan and New Yo...

Read Article
Featured Health News photo

Article Timeline

Newest
  • Newest
  • Oldest
2025
2024
2022
Article Image

Consumers living in rural areas may struggle to receive cardiovascular care, study finds

A new study conducted by researchers from the Beth Israel Deaconess Medical Center found that rural living may pose a risk to consumers’ heart health. Their work showed that consumers who live in rural areas may struggle to get access to medical care for serious cardiovascular issues. 

“Although public health and policy efforts to improve rural health have intensified over the past decade, our findings highlight that large gaps in clinical outcomes for cardiovascular conditions remain in the United States,” said researcher Dr. Rishi K. Wadhera.

“These disparities suggest that rural adults continue to face challenges accessing the care they need for urgent conditions, an issue that has likely been magnified by the rapid rise in rural hospital closures over the last decade.” 

Identifying risks for rural consumers

For the study, the researchers analyzed data from more than two million consumers on Medicare. All of the participants were over the age of 65 and had been hospitalized with heart issues between 2016 and 2018. 

The researchers identified several concerns with rural health care, but especially with emergency health care in rural areas for cardiovascular patients. For starters, the study showed that mortality rates in rural hospitals were higher than in urban hospitals. The researchers also found that patients are less likely to receive typical procedures given to those having a heart attack or stroke in rural hospitals.

Despite these concerning findings, the study also revealed one positive outcome. 

“One bright spot is that we found that the subgroup of older adults who present to rural hospitals with a very severe type of heart attack – known as ST elevation myocardial infarction, or STEMI – experience similar outcomes as their urban counterparts,” Dr. Wadhera said. “This is good news, and suggests that concerted public health initiatives over the past decade, like regional systems of care and transfer protocols, have helped eliminate the rural-urban gap in outcomes for the most emergent type of heart attack.” 

What is different in rural areas? 

The researchers point to several different reasons for disparities in health care for patients in rural areas. They explained that many hospitals in these regions aren’t as well-staffed as hospitals in more populated areas. This can make it difficult for follow-ups, scheduling rehabilitation sessions, or even discharging patients following a cardiovascular issue. 

The researchers also found that rural hospitals aren’t as well-equipped for cardiovascular patients because they may lack the tools and resources necessary to properly treat these serious conditions. Additionally, the team explained that many hospitals in rural areas have closed in recent years. This adds the burden of travel to high-risk patients who require emergency care, which can make it difficult for them to receive treatments in a timely fashion. 

Moving forward, the researchers hope these findings emphasize the need for even stronger public health efforts geared towards emergency medical care in rural areas.  

“Our findings highlight that ongoing public health, policy, and clinical efforts are needed to close the gaps in outcome for urgent cardiovascular conditions, such as heart attacks and stroke,” said researcher Dr. Emefah C. Loccoh. 

A new study conducted by researchers from the Beth Israel Deaconess Medical Center found that rural living may pose a risk to consumers’ heart health. Thei...

2020
Article Image

FDA investigating two E. coli outbreaks

The U.S. Food and Drug Administration (FDA) is working with various state governments to track down the origin of two new E. coli outbreaks. 

At this point, the agency says there are a lot of unknowns. What is known is that the illnesses have been caused by Shiga toxin-producing E. coli O157:H7 (STEC).

“We do not know what food is causing people to get sick or whether it involves an FDA-regulated food product,” said  Frank Yiannas, FDA deputy commissioner for Food Policy and Response. “However, we have seen similar recurring, emerging or persistent strains of E. coli in recent outbreaks.” 

“E. coli O157:H7 can contaminate many foods, and we cannot assume that the current outbreaks are linked to historically associated foods like romaine and other leafy greens,” the agency added. “There is no information currently to indicate that people should avoid any specific food.”

One of the E. coli outbreaks is being caused by a strain that is genetically related to a strain that caused the 2019 STEC outbreak linked to romaine grown in the California Central Coast Salinas growing region. To date, health officials have documented 23 cases and no deaths.

The second outbreak is being caused by a strain that is genetically related to a larger, diverse genetic cluster including the strain that caused the 2018 STEC outbreak linked to romaine and environmental isolates from the Yuma, Arizona growing region. To date, 21 cases and one death have been reported.

‘Transparency and early communication’

"We are issuing this update early in our investigation as part of our continued commitment to transparency and early communication,” Yiannas said. “We are also working toward making a new resource available soon on our website to provide early updates on new and active investigations.

Because the origin of the two outbreaks is still a mystery, consumers should take precautions when consuming uncooked produce. Produce should be carefully and thoroughly washed before serving. The FDA offers these guidelines for safe storage and preparation of produce.

The 2019 E. coli outbreak finally ended in January of this year, an outbreak linked to California-grown romaine lettuce. In total, 167 people across 27 different states were infected by tainted products. Of that number, 85 consumers were hospitalized and 15 developed hemolytic uremic syndrome, which is a type of kidney failure. Luckily, there were no deaths linked to the outbreak. 

The U.S. Food and Drug Administration (FDA) is working with various state governments to track down the origin of two new E. coli outbreaks. At this po...